COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1995-4484-2014-277-282
Abstract
Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA).
Objective: to study the associations of the data of high-resolution computed tomography (HRCT) and the esti- mate of diffusing lung capacity (DLC) with clinical and laboratory parameters in RA patients with and without ILD.
Subjects and methods. 79 RA patients fulfilling the 1987 American College of Rheumatology criteria (61 women and 18 men) admitted to the Nasonova Research Institute of Rheumatology were included.
Results. HRCT revealed signs of ILD in 58 (73%) cases. The patients with ILD were divided into three groups: 1) 18 (31%) patients with ground glass opacities; 2) 34 (58.6%) patients with fibrosis; 3) 6 (10.4%) patients with the honeycomb lung. Twenty-one (27%) patients with ILD were included in Group 4. In the ILD patients with ground glass opacities, the levels of anti-cyclic citrullinated peptide (ACCP) antibodies and rheumatoid factor (RF) were much above those in the patients without ILD (240 [166; 410.5], 480 [140; 850.5] and 73 [31; 101], 330,5 [118.5; 604.8], respectively). In the patients with ILD, the concentration of C-reactive protein (CRP) (46 [35; 91]) was higher than that in those without ILD (24 [18; 31]; p < 0.05). In the ILD patients with ground glass opacities, DLC was considerably below that in those with ILD – 59.2±11.2 and 79.8±12.1% of the normal value, respectively (p < 0.001).
Conclusion. The associations found between ACCP antibodies and DLC, DAS28 and DLC may suggest that ACCP antibodies are implicated in the pathogenesis of ILD and the lung is involved in the immunoinflammatory process. The high percent of smokers detected in our investigation confirms the considerable role of smoking in the pathogene- sis of RA-associated ILD. In the RA patients with ILD, ground glass opacities must be an indicator of the activity of an immunopathological process in the lung.
About the Authors
D. V. Bestaev
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
L. A. Bozhyeva
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
N. O. Nikonorova
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
S. I. Glukhova
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
D. E. Karateev
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
E. L. Nasonov
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
References
1. Насонов ЕЛ, Каратеев ДЕ, Балабанова РМ. Ревматоидный артрит. В кн.: Ревматология. Национальное руководство. Под ред. Е.Л. Насонова, В.А. Насоновой. Москва: ГЭОТАР- Медиа; 2008. С. 290–331. [Nasonov EL, Karateev DE, Balabanova RM. Rheumatoid arthritis. In: Revmatologiya. Natsional'noe rukovodstvo [Rheumatology. National Guide]. Moscow: GEOTAR-Media; 2008. P. 290–331.]
2. Lee DM,Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903–11. DOI: http://dx.doi.org/10.1016/S0140- 6736(01)06075-5.
3. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):525–35.
4. Froidevaux-Janin S, Dudler J, Nicod LP, Lazor R. Interstitial lung disease in rheumatoid arthritis. Rev Med Suisse. 2011 Nov 23;7(318):2272–7.
5. Mayberry JP, Primack SL, Muller NL. Thoracic manifestations of systemic autoimmune diseases: radiographic and high-resolution CT findings. Radiographics. 2000;20(6):1623–35.
6. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lungs diseases: CT findings. Radiology. 2004;232(1):81–91. DOI: http://dx.doi.org/10.1148/radiol.2321030174. Epub 2004 May 27.
7. Webb WR, Muller NL, Naidich DP. High-resolution CT of the lung, 3rd ed. Baltimore: Lippincott, Williams & Wilkins; 2001.
8. Reynisdottir G, Nyren S, Harju A, et al. Lung changes detected by high resolution tomography are present in ACPA positive RA patients already at disease onset. Am Coll Rheumatol. 2011;63:2176.
9. Юдин АЛ, Афанасьева НИ, Абович ЮА, Георгиади СГ. Компьютерная томография высокого разрешения
10. в диагностике интерстициальных пневмоний. Медицинская визуализация. 2002;4:40–8. [Yudin AL, Afanas'eva NI, Abovich YuA, Georgiadi SG. Computer tomography of high resolution in diagnostics the interstitsialnykh of pneumonia. Meditsinskaya vizualizatsiya. 2002;4:40–8. (In Russ.)]
11. Ascherman DP. Interstitial lung disease in rheumatoid arthritis.Curr Rheumatol Rep. 2010;12(5):363–9. DOI: 10.1007/s11926-
12. -0116-z.
13. Cervantes-Peres P, Toro-Perez AH, Rodriguez-Jurado P. Pulmonary inwolvement in rheumatoid arthritis. JAMA. 1980;243(17):1715–59. DOI: http://dx.doi.org/10.1001/jama.1980.03300430017014.
14. Liu G, Friggeri A, Yang Y, Milosevic J, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207(8):1589–97. DOI: 10.1084/jem.20100035. Epub 2010 Jul 19.
15. Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associ- ated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics. 2002;22 Spec No:S151–65. DOI: http://dx.doi.org/10.1148/radiographics.22.suppl_1.g02oc04s151.
16. Демина AB, Раденска-Лоповок СГ, Фоломеева ОM, Эрдес Ш. Причины смерти у больных с ревматическими заболеваниями в Москве. Терапевтический архив. 2005;77(4):77–82. [Demina АВ, Radaneska-Lopovok SG, Folomeeva OM, Erdes Sh. Causes of death in patients with rheu- matic diseases in Moscow. Terapevticheskii arkhiv. 2005;77(4):77–82. (In Russ.)]
17. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62(6):1583–91. DOI: http://dx.doi.org/10.1002/art.27405.
18. Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung diseases. The relevance of histopathologic and radiographic pattern. Chest. 2009;136(5):1397–405. DOI: 10.1378/chest.09-0444.
19. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in RA patients that carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis. 2006 Mar;65(3):366–71. DOI: http://dx.doi.org/10.1136/ard.2005.041079. Epub 2005 Jul 13.
20. Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998;41(5):817–22. DOI: http://dx.doi.org/10.1002/1529- 0131(199805)41:5%3C817::AID-ART7%3E3.0.CO;2-S.
21. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168(2):159–66. DOI: 10.1001/archinternmed.2007.59.
22. Rajasekaran AB, Shovlin D, Lord P, Kelly CA. Interstitial lung disease in patients with rheumatoid arthritis; a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford). 2001;40(9):1022–5. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/40.9.1022.
23. Miller MR, Hankinson J, Brusasco V, et al.; ATS/ERS task force. Standardization of spirometry. Eur Resp J. 2005;26(2):319–38. DOI: http://dx.doi.org/10.1183/09031936.05.00034805.
24. Черняк АВ, Неклюдова ГВ. Диффузионная способность легких. В кн.: Функциональная диагностика
25. в пульмонологии. Практическое руководство. Под ред.
26. А.Г. Чучалина. Москва: Атмосфера; 2009. С. 94. [Chernyak AV, Neklyudova GV. Diffusive ability of lungs. In: Funktsional'naya diagnostika v pul'monologii. Prakticheskoe rukovodstvo [Functional diagnostics in pulmonology. Practical Guide]. Chuchalin AG, edi- tor. Moscow: Atmosfera; 2009. P. 94.]
27. Wedzicha JA, Bestall JC, Garrod R, et al. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pul- monary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J. 1999;12(2):363–9. DOI: http://dx.doi.org/10.1183/09031936.98.12020363.
28. Bilgici A, Ulusoy H, Kuru O, et al. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 2005;25(6):429–35. DOI: http://dx.doi.org/10.1007/s00296-004-0472-y.
29. Giles JT, Danoff SK, Sokolove J, et al. Association of fine speci- ficity and repertoire expansion of anticitrullinated peptide anti- bodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis. 2013 May 28. DOI: http://dx.doi.org/10.1136/annrheumdis-2012-203160.
30. Inui N, Enomoto N, Suda T, et al. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthri- tis. Clin Biochem. 2008 Sep;41(13):1074–7. DOI: 10.1016/j.clin- biochem.2008.06.014. Epub 2008 Jul 3.
31. Mohd Noor N, Mohd Shahrir MS, Shahid MS, et al. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis. 2009 Jul;12(2):136–44. DOI: 10.1111/j.1756-185X.2009.01376.x.
32. Gizinski AM, Mascolo M, Loucks JL, et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung dis- ease and absence of clinically apparent articular RA. Clin Rheumatol. 2009;28(5):611–3. DOI: 10.1007/s10067-009-1128-9. Epub 2009 Feb 28.
33. Klareskog L, Stolt P, Lundberg K, et al. Epidemiological Investigation of Rheumatoid Arthritis Study Group. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA- DR (shared epitope) – restricted immune reactions to autoanti- gens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46. DOI: http://dx.doi.org/10.1002/art.21575.
34. Baka Z, Edit Buzas E, Nagy G. Rheumatoid arthritis and smok- ing: putting the pieces together. Arthritis Res Ther. 2009;11(4):238–41. DOI: http://dx.doi.org/10.1186/ar2751.
35. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, et al. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA- DRB1 shared epitope alleles. Arthritis Rheum. 2007;56(9):2913–8. DOI: http://dx.doi.org/10.1002/art.22845.
36. Demoruelle M, Weisman M, Derber L, et al. Lung abnormalities in subjects with elevations of rheumatoid arthritis-related autoanti- bodies without arthritis by examination and imaging suggest the lung is an early and perhaps initiating site of inflammation in rheumatoid arthritis. Ann Rheum Dis. 2012;71:A25 DOI: 10.1136/annrheumdis-2011-201231.16.
37. Padyukov L, Silva C, Stolt P, et al. A gene environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3085–92. DOI: http://dx.doi.org/10.1002/art.20553.
Review
For citations:
Bestaev D.V., Bozhyeva L.A., Nikonorova N.O., Glukhova S.I., Karateev D.E., Nasonov E.L. COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2014;52(3):277-282. (In Russ.) https://doi.org/10.14412/1995-4484-2014-277-282
Views:
1360
Email this article 